Description
Maven Regulatory Solutions proudly attended CPHI Frankfurt 2025, one of the world’s largest pharmaceutical trade fairs connecting the global pharma supply chain across APIs, excipients, finished dosage formulations, CDMOs, CROs, packaging, and regulatory service providers. Hosted in Frankfurt, the event served as a strategic platform for international pharmaceutical collaboration, innovation, and regulatory alignment.
CPHI Frankfurt continues to be a global meeting point for drug development, manufacturing excellence, biologics expansion, advanced drug delivery systems, and digital transformation in pharma operations. The exhibition facilitated high-level discussions on regulatory harmonization, sustainability in pharma manufacturing, supply chain resilience, and AI-driven pharmaceutical technologies.
Maven Regulatory Solutions – Global Regulatory & Compliance Focus
During CPHI Frankfurt 2025, Maven Regulatory Solutions engaged with global stakeholders on:
- End-to-end regulatory submissions (CTD/eCTD publishing & lifecycle management)
- EU, US, GCC & emerging market regulatory pathways
- Pharmacovigilance system setup, signal detection & risk management plans (RMPs)
- Regulatory Information Management Systems (RIMS) implementation
- Post-approval variations & global change management
- Biologics, biosimilars & specialty pharma compliance strategy
- Digital regulatory transformation & automation solutions
Our participation strengthened international partnerships across pharmaceutical manufacturing, biotech innovation, and regulatory technology sectors while reinforcing Maven’s expertise in global regulatory affairs consulting, pharmacovigilance compliance, and strategic market authorization support.
CPHI Frankfurt 2025 remains a key milestone event shaping the future of global pharmaceutical development, regulatory science, and cross-border healthcare collaboration — aligning with Maven’s mission to deliver compliant, technology-enabled, and scalable regulatory solutions worldwide.
